A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...

Fact checked by Jennifer Klump A group of advisors to the Centers for Disease Control and Prevention (CDC) voted 5-2 to ...

Respiratory syncytial virus, or RSV, is transmitting at about 10 to 11 times the number typically seen at this time of year in Pima County, co… Masks urged amid COVID-19, respiratory illness ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

SMi Report: Respiratory Drug Delivery conference will be taking place on 5 th – 6 th December 2019, the brochure is now available to download. With the rising prevalence of respiratory diseases ...

Respiratory tract diseases are illnesses that affect components of the respiratory system, including the nasal passages, the bronchi and the lungs. They range from acute infections, such as ...

Hepatitis B virus (HBV) infection is associated with hepatitis and hepatocellular carcinoma (HCC). Here, the authors show that HBV promotes HCC formation only in response to environmental ...

Aug. 19, 2024 — A multidisciplinary team has developed an action plan to help patients with respiratory diseases mitigate the consequences of poor air quality from ... Tuesday, December 10, 2024 ...